Jeong-ryeol Gong
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
NetG2P: Network-based genotype-to-phenotype transformation identifies key signaling crosstalk for prognosis in pan-cancer study.
Journal: BMC biology
Published: September 05, 2025
DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 02, 2025
Superloaded Multiplexed scRNA-seq Data Preserves Primary Immune Cell Heterogeneity but Necessitates Stringent Doublet Removal.
Journal: Immunological investigations
Published: January 30, 2025
Identification of a unique subpopulation of mucosal fibroblasts in colorectal cancer with tumor-restraining characteristics.
Journal: Molecules and cells
Published: December 12, 2024
Attractor Landscape Analysis Reveals a Reversion Switch in the Transition of Colorectal Tumorigenesis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 07, 2024
Deciphering Dysfunctional Regulatory T Cells in Atopic Dermatitis.
Journal: Allergy
Published: July 26, 2024
Simultaneous Epigenetic and Gene Expression Profiling at Single Cell Resolution Uncovers Stem-Like Treg Subsets Induced With Oligonucleotide Expansion in Humans.
Journal: Immune network
Published: March 21, 2024
Unveiling the dynamics of B lymphocytes in systemic lupus erythematosus patients treated with belimumab through longitudinal single-cell RNA sequencing.
Journal: Rheumatology (Oxford, England)
Published: March 08, 2024
Control of Cellular Differentiation Trajectories for Cancer Reversion.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 28, 2024
A gray box framework that optimizes a white box logical model using a black box optimizer for simulating cellular responses to perturbations.
Journal: Cell reports methods
Published: May 13, 2023
The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients-a randomized trial.
Journal: Leukemia
Published: October 21, 2022
Last Updated: 09/26/2026